256 related articles for article (PubMed ID: 34390440)
1. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis.
Frede N; Rojas-Restrepo J; Caballero Garcia de Oteyza A; Buchta M; Hübscher K; Gámez-Díaz L; Proietti M; Saghafi S; Chavoshzadeh Z; Soler-Palacin P; Galal N; Adeli M; Aldave-Becerra JC; Al-Ddafari MS; Ardenyz Ö; Atkinson TP; Kut FB; Çelmeli F; Rees H; Kilic SS; Kirovski I; Klein C; Kobbe R; Korganow AS; Lilic D; Lunt P; Makwana N; Metin A; Özgür TT; Karakas AA; Seneviratne S; Sherkat R; Sousa AB; Unal E; Patiroglu T; Wahn V; von Bernuth H; Whiteford M; Doffinger R; Jouhadi Z; Grimbacher B
J Clin Immunol; 2021 Nov; 41(8):1804-1838. PubMed ID: 34390440
[TBL] [Abstract][Full Text] [Related]
2. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
3. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
4. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
5. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
[TBL] [Abstract][Full Text] [Related]
6. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
7. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
Alcántara-Montiel JC; Vega-Torres BI
Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
[TBL] [Abstract][Full Text] [Related]
8. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
[TBL] [Abstract][Full Text] [Related]
9. Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and/or neonatal rash: Evidence from the Italian cohort of 61 patients with elevated IgE.
Lorenzini T; Giacomelli M; Scomodon O; Cortesi M; Rivellini V; Dotta L; Soresina A; Dellepiane RM; Carrabba M; Cossu F; Cancrini C; Specchia F; Giardino G; Pignata C; Plebani A; Pietrogrande MC; Badolato R;
J Allergy Clin Immunol Pract; 2019; 7(6):2072-2075.e4. PubMed ID: 30797078
[No Abstract] [Full Text] [Related]
10. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.
Aydin SE; Kilic SS; Aytekin C; Kumar A; Porras O; Kainulainen L; Kostyuchenko L; Genel F; Kütükcüler N; Karaca N; Gonzalez-Granado L; Abbott J; Al-Zahrani D; Rezaei N; Baz Z; Thiel J; Ehl S; Marodi L; Orange JS; Sawalle-Belohradsky J; Keles S; Holland SM; Sanal Ö; Ayvaz DC; Tezcan I; Al-Mousa H; Alsum Z; Hawwari A; Metin A; Matthes-Martin S; Hönig M; Schulz A; Picard C; Barlogis V; Gennery A; Ifversen M; van Montfrans J; Kuijpers T; Bredius R; Dückers G; Al-Herz W; Pai SY; Geha R; Notheis G; Schwarze CP; Tavil B; Azik F; Bienemann K; Grimbacher B; Heinz V; Gaspar HB; Aydin R; Hagl B; Gathmann B; Belohradsky BH; Ochs HD; Chatila T; Renner ED; Su H; Freeman AF; Engelhardt K; Albert MH;
J Clin Immunol; 2015 Feb; 35(2):189-98. PubMed ID: 25627830
[TBL] [Abstract][Full Text] [Related]
11. Hyper IgE Syndromes.
Gracci S; Novelli T; D'Elios S; Bernardini R; Peroni D
Curr Pediatr Rev; 2024; 20(3):253-264. PubMed ID: 37702167
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009-2018).
Xiang Q; Zhang L; Liu X; Wang S; Wang T; Xiao M; Zhao X; Jiang L
Scand J Immunol; 2020 Jun; 91(6):e12885. PubMed ID: 32248557
[TBL] [Abstract][Full Text] [Related]
13. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
14. Primary Immunodeficiencies with Elevated IgE.
Mogensen TH
Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
[TBL] [Abstract][Full Text] [Related]
15. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation.
Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R
Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732
[TBL] [Abstract][Full Text] [Related]
16. Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.
Gernez Y; Freeman AF; Holland SM; Garabedian E; Patel NC; Puck JM; Sullivan KE; Akhter J; Secord E; Chen K; Buckley R; Haddad E; Ochs HD; Fuleihan R; Routes J; Muskat M; Lugar P; Mancini J; Cunningham-Rundles C
J Allergy Clin Immunol Pract; 2018; 6(3):996-1001. PubMed ID: 28939137
[TBL] [Abstract][Full Text] [Related]
17. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
18. No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome.
Renner ED; Pawlita I; Hoffmann F; Hornung V; Hartl D; Albert M; Jansson A; Endres S; Hartmann G; Belohradsky BH; Rothenfusser S
J Clin Immunol; 2005 Jul; 25(4):321-8. PubMed ID: 16133988
[TBL] [Abstract][Full Text] [Related]
19. Hyper IgE syndromes: clinical and molecular characteristics.
Al-Shaikhly T; Ochs HD
Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
[TBL] [Abstract][Full Text] [Related]
20. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
